Department of Psychiatry, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Cambridge, UK.
J Psychopharmacol. 2011 Feb;25(2):197-204. doi: 10.1177/0269881109106926. Epub 2010 Mar 8.
Neuroethics is a developing field, concerned with addressing present and future applied ethical issues brought about directly and indirectly by neuroscience advancements. One domain where neuroscience has begun to have far-reaching ethical implications is in the research and development of pharmaceutical cognitive enhancers. Though such drugs are typically developed to treat cognitive disabilities and improve the quality of life for patients with neuropsychiatric disorders and brain injury, research has found that such drugs can improve performance on cognitive tasks in healthy individuals. In line with such findings is the growing use of these drugs by students and others for cognitive-enhancing purposes. The present paper reviews some of the evidence in both neuropsychiatric and healthy individuals and discusses the implications such research can have for society.
神经伦理学是一个发展中的领域,关注的是直接和间接由神经科学进步带来的当前和未来的应用伦理问题。神经科学在药物认知增强剂的研究和开发方面开始产生深远的伦理影响的一个领域是,尽管这类药物通常是为了治疗认知障碍和改善神经精神疾病和脑损伤患者的生活质量而开发的,但研究发现,这类药物可以提高健康个体的认知任务表现。与这些发现相一致的是,学生和其他人越来越多地将这些药物用于认知增强目的。本文综述了神经精神病学和健康个体中的一些证据,并讨论了此类研究对社会的影响。
J Psychopharmacol. 2010-3-8
Clin Pharmacol Ther. 2017-2
Philos Trans R Soc Lond B Biol Sci. 2015-9-19
Genes Brain Behav. 2003-8
Nat Rev Neurosci. 2004-5
Clin Pharmacol Ther. 2017-2
Neuron. 2011-2-24
Camb Q Healthc Ethics. 2018-10
Psychopharmacology (Berl). 2025-8-5
PLoS Biol. 2024-10
Explor Res Clin Soc Pharm. 2021-12-14
Philos Trans R Soc Lond B Biol Sci. 2022-1-3
Front Neurosci. 2021-5-26
Neuroscientist. 2021-8